首页> 外文学位 >Protein aggregation studies: Inhibiting and encouraging beta-amyloid aggregation.
【24h】

Protein aggregation studies: Inhibiting and encouraging beta-amyloid aggregation.

机译:蛋白质聚集研究:抑制和鼓励β淀粉样蛋白的聚集。

获取原文
获取原文并翻译 | 示例

摘要

This work demonstrates peptide-based aggregation mediation of fibril forming peptides, notably beta-amyloid (1--40), Abeta1--40 . To achieve the goals of this work, Abeta1--40 aggregation was governed by ionic strength, temperature, and pH. After controlling and reproducing Abeta1--40 aggregate formation (fibrils), each peptide-based aggregation mediator was evaluated for its ability to self-aggregate and to possess surface-active properties. The incorporation of these mediators in Abeta1--40 solutions changed the surface tension and produced aggregate complexes of mediator and Abeta1--40. Evidence that Abeta1--40 fibril formation may be mediated by disorder-to-order transitions has been observed by layer formation on top of a beta-sheet monolayer of another fibril forming, but cyclic, peptide.; Governance of Abeta1--40 aggregation was performed by controlling the environment (ionic strength and temperature) of both the stock and sample conditions. Sample containment was important in controlling aggregation, as a certain brand of vessels induced Abeta1--40 aggregation.; Each peptide-based aggregation mediator was characterized to determine any self-aggregation. It was found that AMY-1, developed at Louisiana State University, and an inhibitor developed by Dr. Regina Murphy at the University of Wisconsin sparsely aggregated. AMY-2, also developed at L.S.U., favored deposition on mica. The Murphy inhibitor produced no change in surface activity over a wide concentration range, while AMY-1 and AMY-2 displayed surface activity and critical micelle concentrations just below 1 mM.; The introduction of some mediators displayed changes in surface tension to solutions of Abeta1--40; Murphy's inhibitor increased the surface tension, whereas AMY-1 and AMY-2 decreased the surface tension of Abeta1--40 solutions. Complex formation between each mediator and Abeta1--40 inhibited fibril formation and formation of amorphous aggregates, as evidenced by scanning force and transmission electron microscopy.; The adsorption of a monolayer of Abeta1--40 onto a beta-sheet monolayer of cyclic peptides was observed. These cyclic peptides, initially thought to be fibril inhibitors, were found to be potent fibril formers themselves and attached only to exposed sites of highly oriented pyrolytic graphite. The ability for a surface to induce fibril formation may allow a more thorough understanding of Abeta1--40 fibril formation.
机译:这项工作表明原纤维形成肽,尤其是β淀粉样蛋白(1--40),Abeta1--40的基于肽的聚集介导。为了实现这项工作的目标,Abeta1--40聚集受离子强度,温度和pH值控制。在控制和复制Abeta1--40聚集体形成(原纤维)后,评估每个基于肽的聚集介体的自聚集能力和表面活性。这些介体在Abeta1--40溶液中的掺入改变了表面张力,并产生了介体和Abeta1--40的聚集复合物。通过在另一种原纤维形成但环状的肽的β-折叠单层的顶部上形成层,已经观察到Abeta1--40原纤维形成可能由无序转变介导的证据。通过控制库存和样品条件的环境(离子强度和温度)来执行Abeta1--40聚集的控制。样品收容对控制聚集非常重要,因为某些品牌的容器会诱导Abeta1--40聚集。每个基于肽的聚集介体的特征在于确定任何自聚集。发现在路易斯安那州立大学开发的AMY-1和由威斯康星大学的Regina Murphy博士开发的抑制剂稀疏聚集。也在L.S.U.开发的AMY-2有利于在云母上沉积。墨菲抑制剂在很宽的浓度范围内表面活性没有变化,而AMY-1和AMY-2的表面活性和临界胶束浓度刚好低于1 mM。一些介体的引入显示了Abeta1--40溶液的表面张力发生了变化。墨菲的抑制剂增加了表面张力,而AMY-1和AMY-2降低了Abeta1--40溶液的表面张力。每个介体和Abeta1--40之间的复合物形成抑制了原纤维的形成和无定形聚集体的形成,如通过扫描力和透射电子显微镜所证明的。观察到Abeta1--40单层吸附到环肽的β-折叠单层上。最初被认为是原纤维抑制剂的这些环状肽被发现是有效的原纤维形成剂本身,并且仅附着于高度取向的热解石墨的暴露部位。表面诱导原纤维形成的能力可以允许对Abeta1--40原纤维形成的更全面的了解。

著录项

  • 作者

    Aucoin, Jed Paul.;

  • 作者单位

    Louisiana State University and Agricultural & Mechanical College.;

  • 授予单位 Louisiana State University and Agricultural & Mechanical College.;
  • 学科 Chemistry Analytical.; Chemistry Biochemistry.
  • 学位 Ph.D.
  • 年度 2004
  • 页码 140 p.
  • 总页数 140
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;生物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号